A subtherapeutic quantity of [177Lu]Lu-DOTA-folate (3.5 Gy tumor dose; 5 MBq/mouse) was chosen to obtain a low-dose radiation stimulus of the tumor prior to immunotherapy with an anti-CTLA-4 antibody (Supplementary Material Fig. S6 and Table S2). Here, CTLA4 is linked to neoplasm.